National summit to provide update on vision problems in US

Article

Washington, DC—The first-ever Focus on Eye Health: A National Summit, part of a week-long series of events Prevent Blindness America (PBA) is presenting, will take place here June 20. It will feature the release of the update of “Vision Problems in the US: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in Americaâ€, in partnership with the National Eye Institute and Johns Hopkins University.

Washington, DC-The first-ever Focus on Eye Health: A National Summit, part of a weeklong series of events Prevent Blindness America (PBA) is presenting, will take place here June 20. It will feature the release of the update of “Vision Problems in the US: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America”, in partnership with the National Eye Institute and Johns Hopkins University.

PBA said this event will serve as a key launching pad for newly revised public health data on vision and eye health. The event will provide updates of two very significant public health reports from PBA-“Vision Problems in the U.S.” and the “Economic Impact of Vision Problems” as well as a variety of public health presentations that will address vision and eye health in the United States.  

Scheduled presentation topics include:

Vision Problems in the U.S: Prevalence of Vision Problems - Dr. David Friedman, Johns Hopkins University.

Economic Impact of Vision Problems - Dr. Kevin Frick, Johns Hopkins University.

National Plan for Eye and Vision Research - Dr. Rick Fisher, National Eye Institute.

Surveillance of Vision Problems - Dr. Paul Lee, University of Michigan.

Co-Morbidities and Vision - Dr. John Crews, Vision Health Initiative, Centers for Disease Control (CDC).

Diabetes and the Eye - Dr. Ann Albright, Division of Diabetes Translation, CDC.

Current gold-level sponsors include Allergan Foundation, American Academy of Ophthalmology, American Optometric Association, Genentech, Transitions Optical, The Vision Council, VSP, and Vision Vitals Foundation. Silver-level sponsors include Alliance for Eye and Vision Research, AMD Alliance International, American Foundation for the Blind, American Health Assistance Foundation, American Public Health Association, Foundation for Eye Health Awareness, Helen Keller International, Jewish Guild Healthcare, Lighthouse International, Lions Club International, Regeneron, Research to Prevent Blindness, School Health, ThromboGenics, Vision 2020 USA, Vistakon, and VisionServe Alliance.

For more articles in this issue of InDispensable, click here.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.